Acta Translational Medicine (ActaTransMed, ISSN: 2521-8662)

Volume 4, Issue 1, 2021

EVOLUTION OF IMIPENEM RESISTANCE IN ESCHERICHIA COLI : A 9-YEAR RETROSPECTIVE SURVEILLANCE REPORT IN A HOSPITAL POPULATION OF SOUTHERN CHINA

Lianfang Xue, Hui Liu, Suishan Qiu, Qinai Zhu, Shasha Li, Liang Ding, Congxiu Ye

Volume 4, Issue 1, 2021, PP1-9

FullText(PDF)‍

THE RESEARCH PROGRESSION OF SEROLOGICAL ANALYSIS OF RECOMBINANT cDNA EXPRESSION LIBRARIES SCREENING ANTIGENS OF ATHEROSCLEROTIC DISEASES

Hongyu Yang, Hao Wang

Volume 4, Issue 1, 2021, PP10-14

FullText(PDF)

DEXMEDETOMIDINE AMELIORATES ISCHEMIA/REPERFUSION-INDUCED ACUTE KIDNEY INJURY BY INHIBITING ENDOPLASMIC RETICULUM STRESS VIA THE NRF2 SIGNALING PATHWAY

Yu Gu, Dianyu Lu, Yonghua Yao, Wei Wei

Volume 4, Issue 1, 2021, PP15-18

FullText(PDF)




About ActaTransMed
ABUIABACGAAgi9HM7wUo9ODBlgMw1BM4_xs

The Acta Translational Medicine (ActaTransMed, ISSN: 2521-8662) is a peer-reviewed journal dedicated to publication of original work and review articles of translational research in medicine. The goal of ActaTransMed is to provide a barrier-free forum for rapid dissemination of novel discoveries in translational research of medical science. Acta Translational Medicine is primarily devoted to original clinical and experimental research papers, but will also publish editorials, review articles, hypothesis, letters to the editors and meeting reports in translational science. For manuscript submission, please follow the journal’s guidelines and visit submission.